About READDI

READDI is retooling the drug discovery and development process to rapidly develop new antiviral drug solutions for the future. These pandemics are bigger than any one company, government or academy. A unique public-private partnership accelerated by open science, READDI has a goal of developing multiple “on the shelf” clinical assets so we are prepared for the next global health pandemic.

READDI brings together leaders from industry, government, philanthropic organizations, and academic research institutions to leverage existing platforms and accelerate the development of new antiviral drugs.

website icon
Website
employees icon
Employees
industry icon
Industry
Research Services
location icon
Headquarter
Chapel Hill, NC 27514, US
description icon
Founded
2020

Frequently Asked Questions about READDI

Who are the decision makers in READDI?

The decision makers in READDI are Fletcher Fairey, Logan Ward, James Rosen, etc. Click to Find READDI decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more